T-MAXIMUM is currently focused on late-stage malignant tumors, and its lead program for recurrent glioma has received clearance to enter Phase II clinical trials. Over the next three years, the ...
Miguel-Angel Perales, MD, spoke with Targeted Oncology® about the problems the CAR T Vision group has identified and the key ...
News-Medical.Net on MSN
Remodeling the tumor microenvironment to unlock CAR-T cell potential
Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized hematologic cancer treatment, but its efficacy in solid tumors remains limited by poor infiltration into the complex tumor ...
The lack of fuel availability for hydrogen fuel-cell vehicles has prompted 700 Mirai owners to sue Toyota, an attorney said.
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the 'Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D.
Now, with the European Union Health Technology Assessment (HTA) regulation coming into force as part of the required Joint Clinical Assessment (JCA) for oncology and advanced therapy medicinal ...
Cell phones and screens can help kids learn in school. In an increasingly technological world, prudent use of technology will ...
Flock Safety technology helped Providence Police track down 48-year-old Claudio Neves Valente, who police say was responsible for both the Brown University shooting and the killing of an MIT professor ...
Claudio Neves Valente, the suspect in the Brown University mass shooting, was found dead tonight after taking his own life, Providence Chief of Police Oscar L. Perez, Jr. said. Follow for live news ...
Humanity has sent into space everything from lightsabers and Tesla Roadsters to golden records and entire digital genetic ...
An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with ...
Researchers at the University of Sharjah are exploring a promising approach that could enhance the immune system's ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results